Research Paper Volume 16, Issue 11 pp 10074—10107
Immunotherapy, prognostic, and tumor biomarker based on pancancer analysis, SMARCD3
Figure 1. Expression of SMARCD3 in pan-cancer. (A) Expression difference of SMARCD3 between tumor samples and normal tissue; (B) Ranking of SMARCD3 expression in pan-cancer.